You can rely on Cerba Research to outsource your research questions, including efficacy, safety, passive immunization, immunogenicity, pharmaco kinetics, pathogenicity, antiviral therapy, antiviral prophylaxis, drug delivery, resistance mutants, and more.
With more than 4500m2 clinical laboratories, equipped with the latest technologies, we have the in-house capabilities to perform several read outs. We are experts on evaluation of immune responses, antibody detection, vaccine efficacy; immunogenicity, pharmaco kinetics, immunopathology, antiviral therapy, antiviral prophylaxis and more. Our portfolio of immunological assays include: Haemagglutination inhibition, Neutralizing antibodies, Neuraminidase inhibition, cell mediated immunity and immunogenicity testing.
Our Immunoassays
We offer a wide range of immunoassay services tailored to meet your specific research needs. Our team of experienced scientists and technicians employ cutting-edge technologies and industry best practices to deliver accurate and precise results. Whether you require qualitative or quantitative analysis, we have the expertise to support your project at every stage.
We offer a diverse array of assays designed to detect binding antibodies. Our portfolio includes highly effective lateral flow immunoassays, ELISA, ELLA, MSD and chemiluminescence immunoassays. These assays utilize state-of-the-art techniques to identify and quantify binding antibodies with precision and sensitivity.
In addition to binding antibody assays, we provide specialized assays for the detection of neutralizing antibodies (nAbs). Our virus neutralization assays are specifically designed to evaluate the effectiveness of antibodies in inhibiting viral activity. These assays play a crucial role in assessing the immune response and vaccine development. We also continuously add new nAbs to ensure the highest specificity is garnered based on the latest research.
At Cerba Research we understand the importance of precise quantification in immunological research. That’s why we offer highly sensitive immunoassays such as ELISpot and hemagglutination inhibition which enable accurate measurement and characterization of immune responses. These assays provide valuable insights into immune cell function and aid in evaluating vaccine efficacy, disease progression, and treatment effectiveness.
Our ligand binding assays (LBAs) are designed to accommodate a wide range of ligands across various applications. Whether you are studying small proteins, antibodies, or other biomolecules, our assays provide a robust and flexible platform to meet your specific research or diagnostic need.
At Cerba Research we understand the importance of precise quantification in immunological research. That’s why we offer highly sensitive immunoassays such as ELISpot and hemagglutination inhibition which enable accurate measurement and characterization of immune responses. These assays provide valuable insights into immune cell function and aid in evaluating vaccine efficacy, disease progression, and treatment effectiveness.
Cutting-Edge Platforms
To support the development, validation, and implementation of our immunoassays, we employ the most advanced platforms in the industry. Our expertise extends to ELISA, MSD, ELLA, and Luminex, ensuring optimal performance and reproducibility for every project. Our off-the-shelf 37-plex MSD panel is currently in high usage within many of our trials.
Clinical value of our 37-plex MSD panel: Many diseases are characterized by inflammatory processes. Cytokines, as mediators of inflammation, may serve as biomarkers to characterize disease progression and therapy response. The 37-plex MSD panel is also relevant for cytokine release syndrome (CRS) safety assessment which is useful for cell & gene therapy trials.
Customized Immunoassay Test Solutions
If we don’t have it, we can customize it. We understand that each research project is unique, requiring tailored immunoassay test solutions. Our experienced scientists work closely with you to design and optimize assays tailored specific to your research needs. We offer flexible options to accommodate various sample types.
Quality Assurance and Regulatory Compliance
Delivering reliable and high-quality data is our utmost priority. Cerba research diagnostic laboratory has adopted a high-quality standard in all operations, testing procedures and reporting. The quality management system is based on ISO 15189, GLP, GCLP, GSLP, and expanded with elements of GCP, to comply with regulatory requirements and facilitate regulatory submissions. Our commitment to quality ensures that your research findings are robust, reliable, and ready for further development.
Check our 37-plex off-the-shelf MSD assay
Reach out to our experts and see how we can help advance your clinical trial